Dr Dorothy Machalek is a Senior Research Fellow at the Kirby Institute and an Honorary Research Fellow with the Centre for Women’s Infectious Disease at The Royal Women’s Hospital in Melbourne. She holds a Doctorate in epidemiology and a Master of Public Health from the University of New South Wales. Her research focuses on the development and implementation of novel public health surveillance systems, and the evaluation of vaccination and screening strategies for the prevention of HPV and related diseases. Dr Machalek has led the development and implementation of a Commonwealth Department of Health-funded National HPV Monitoring Program (called IMPACT), the methodology of which has underpinned the design of a world-first project to evaluate the impact of one and two-dose HPV vaccine schedules in South Africa funded by NHMRC and the Bill and Melinda Gates Foundation.

Professor Andrew Grulich is a medical epidemiologist and Public Health Physician. He is head of the HIV Epidemiology and Prevention Program at the Kirby Institute, UNSW Australia. He is a governing council member of the International AIDS Society. His research interests include the links between infection, immune function and cancer; and the transmission and prevention of HIV and sexually transmitted infections in homosexual men. He was principal investigator of the Study of Prevention of Anal Cancer (SPANC), a cohort study investigating anal cancer screening

Dr Terri Foran is a Sexual Health Physician and has a special interest in contraception, menopause issues and the management of sexually transmitted infections. She is presently engaged in both clinical and research work at the Royal Hospital for Women in Sydney. Dr Foran holds the position of Conjoint Senior Lecturer at the University of New South Wales in the School of Women’s and Children’s Health.